Quintin Pan PhD

Quintin Pan PhD
Assoc ProfessorCollege of Medicinepan.116@osu.edu
442 Tzagournis Med Res Facility 420 W 12th Avenue Columbus Ohio 43210
Phone:614-247-4438Fax:
  • Experimental Therapeutics

Current Publications

  • Solove RJEmerging role of nanog in tumorigenesis and cancer stem cells.Int J Cancer 12/21/2013
  • Zhang M, Taylor CE, Piao L, Datta J, Bruno PA, Bhave S, Su T, Lang JC, Xie X, Teknos TN, Pan Q, Mapp AKGenetic and chemical targeting of epithelial-restricted with serine box reduces EGF receptor and potentiates the efficacy of afatinib.Mol Cancer Ther 12(8) 1515-25 8/1/2013
  • Xie X, Piao L, Cavey GS, Old M, Teknos TN, Mapp AK, Pan QPhosphorylation of Nanog is essential to regulate Bmi1 and promote tumorigenesis.Oncogene in press 5/27/2013
  • Smith A, Teknos TN, Pan QEpithelial to mesenchymal transition in head and neck squamous cell carcinoma.Oral Oncol 49(4) 287-92 4/1/2013
  • Xie X, Piao L, Bullock BN, Smith A, Su T, Zhang M, Teknos TN, Arora PS, Pan QTargeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma.Oncogene in press 3/11/2013
  • Datta J, Smith A, Lang JC, Islam M, Dutt D, Teknos TN, Pan QmicroRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cɛ.Oncogene 31(36) 4045-53 9/6/2012
  • Piao L, Zhang M, Datta J, Xie X, Su T, Li H, Teknos TN, Pan QLipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma.Mol Ther 20(6) 1261-9 6/1/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu